Overview
DOC market data
Price History
DOC price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for DOC. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Healthpeak Properties And Brookfield Asset Management Form $2.1B Long-Term Strategic Capital JV Involving Portfolio Of Outpatient Medical Buildings Across USBenzinga · Jul 20, 2026, 10:47 AM
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $22Benzinga · Jul 15, 2026, 11:32 AM
UBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $21.5Benzinga · Jul 8, 2026, 6:30 PM
Mizuho Maintains Outperform on Healthpeak Properties, Raises Price Target to $24Benzinga · Jul 6, 2026, 12:35 PM
Raymond James Reinstates Market Perform on Healthpeak PropertiesBenzinga · Jun 17, 2026, 2:25 PM
BMO Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24Benzinga · Jun 15, 2026, 2:55 PM
Morgan Stanley Downgrades Healthpeak Properties to Equal-Weight, Raises Price Target to $22Benzinga · Jun 11, 2026, 4:36 PM
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $20Benzinga · Jun 1, 2026, 3:21 PM
Scotiabank Maintains Sector Perform on Healthpeak Properties, Raises Price Target to $21Benzinga · May 27, 2026, 2:40 PM
Morgan Stanley Maintains Overweight on Healthpeak Properties, Raises Price Target to $20Benzinga · May 22, 2026, 5:20 PM